Eco Science Solutions, Inc.

Eco Science Solutions, Inc. focuses on developing consumer and enterprise technology products and services for consumers, companies, brands, and entrepreneurs to transact business in the cannabis and CBD hemp industries. It offers Herbo enterprise software suite, a business software and resource, which provides software, custom web development, operational training, and support to plan and manage marijuana or CBD business. The company was incorporated in 2009 and is headquartered in Makawao, Hawaii.

Eco Science Solutions, Inc. trades as ESSI on OTC. The company is classified in Healthcare / Medical - Healthcare Information Services and reports in USD.

The current profile places the business in Medical - Healthcare Information Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $0 of revenue and -$1.10M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Eco Science Solutions, Inc. can be compared against peers such as Cannabis Suisse Corp., Elixinol Wellness Limited, Helix BioMedix, Inc., Newtopia Inc., Next Generation Management Corp., Orgenesis Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $308,636, beta of -57.12, and return on equity of +6.7%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ESSI currently shows total debt of $6.91M and beta of -57.12. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: NT 10-K (2026-05-01 00:00:00), 8-K (2026-03-12 00:00:00), PRE 14C (2026-03-12 00:00:00), 8-K (2026-02-09 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.useherbo.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.